SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital is trending following a significant announcement that the company is selling Bitcoin to repurchase convertible debt, a move aimed at deleveraging its balance sheet that has sparked intense debate over management's long-term strategy and Bitcoin-holding ideology. While some traders are optimistic about a potential short squeeze and institutional re-rating as the company pivots toward AI data center operations, the community remains deeply divided, with many vocal critics condemning leadership for perceived financial mismanagement and past share dilution.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing intense downward pressure as investors grow increasingly skeptical of the company's aggressive AI capital expenditures and the perceived lack of immediate profitability from its Copilot integration. Despite the prevailing bearish sentiment, the community is deeply divided between those calling for a total trend reversal and long-term advocates who view the current price compression as a generational buying opportunity for a fundamental cloud powerhouse.

Maase, Inc. engages in the provision of intelligent technology-driven family and enterprise services. It operates through the following business segments: Insurance Agency and Wealth Management. The Insurance Agency segment involves in providing agency services for distributing life and non-life insurance products on behalf of insurance companies. The Wealth Management segment offers financial advisory, investment planning, and asset management services for individuals, families, and corporate clients, utilizing data-driven insights and digital platforms to optimize financial outcomes. The company was founded by Hai Feng Yu on August 6, 2018, and is headquartered in Guangzhou, China.

Maase Inc. - Ordinary Shares - Class A

Highest Performances Holdings Inc. - ADR

MAAS is gaining momentum as investors pivot from theoretical potential to tangible execution, highlighted by the confirmed deployment of mobile charging units and a new focus on AI-driven energy infrastructure. The community is actively debating whether the companys recent acquisitions and shift toward a 'distributed energy network' model will lead to a successful valuation re-rating.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin shares are experiencing extreme volatility and intense retail debate as traders weigh potential AI-driven growth against ongoing concerns regarding institutional competition and short-seller reports. While bulls cite the company's strong ad-tech performance and potential for a massive short squeeze as catalysts for a rally, bears remain skeptical, highlighting insider selling and broader market headwinds as reasons for caution.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences is experiencing significant market volatility following a recent stock offering and investor reaction to Phase 1 data for its obesity candidate, WVE-007. While the community remains sharply divided, active discussions are focused on whether the sell-off represents a temporary overreaction to financing or a broader reassessment of the drug's competitive positioning against established GLP-1 treatments.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

Adma Biologics is facing intense volatility and downward pressure following a highly critical short report from Culper Research that alleges channel stuffing and undisclosed related party transactions. While management has dismissed the claims as speculative and inaccurate, investors remain divided, with the community actively debating whether the drop is an irrational reaction to a hit piece or a warning sign that requires a more detailed, accountant-backed rebuttal to restore institutional confidence.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is currently under pressure as investors react to a combination of geopolitical tensions and mounting concerns over the company's aggressive spending on AI infrastructure. The community is actively debating the stock's future, with many users speculating on upcoming layoff announcements while others view the current price action as a buying opportunity for long-term holders.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiak Sciences is trending as shares rally following positive topline results from the Phase 3 GLOW2 study of Zenkuda for diabetic retinopathy, with investors actively discussing the potential for a short squeeze given high short interest. The community is heavily focused on the drug's demonstrated superiority over placebo, fueling speculation about the company's prospects as an acquisition target.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is experiencing heightened volatility as market participants weigh conflicting headlines regarding Iran-U.S. negotiations against the threat of ground operations and potential energy supply disruptions. Community sentiment remains deeply polarized and anxious, with traders closely monitoring geopolitical developments, oil price movements, and cryptic official communications for signals on whether to hedge or capitalize on the ongoing instability.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is currently trending as investors weigh strong CPU demand and institutional interest in AI hardware against geopolitical uncertainties and supply chain constraints. The community remains divided, with active debates centered on whether recent price hikes signal long-term fundamental strength or if broader market volatility will lead to a deeper correction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Kodiak Sciences (KOD) jumped nearly 40% in pre-market trading on Thursday, after the pharmaceutical firm reported positive Phase 3 results for its eye drug Zenkuda to treat patients with diabetic retinopathy.The study met its primary endpoint as a total of 62.5% of patients treated with Zenkuda achieved at least a two-step improvement in DRSS score, a measure of severity, by week 48, compared with just 3.3% in the control group. The drug also reduced the risk of sight-threatening complications by 85% through Week 48.Zenkuda delivered consistent benefits regardless of GLP-1 use, with 60% of patients on GLP-1 therapies achieving a two-step DRSS improvement by Week 48, compared to 64.3% among those not using GLP-1 drugs. The treatment was well tolerated, with no cases of intraocular swelling and low rates of side effects.“We now have a multi-indication BLA-ready profile for Zenkuda, and we intend to accelerate our BLA submission plans,” said Victor Perlroth, CEO of Kodiak Sciences.Get updates to this developing story on Stocktwits.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

Tariff uncertainty has prompted several analysts to cut their price targets for Five9 stock. 

Why Did KOD Stock Surge 40% In Pre-Market Today?

The company said its Phase 3 trial to treat diabetic retinopathy met its primary endpoint.

Equity

Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda (tarcocimab tedromer) Over Sham

Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda (tarcocimab tedromer) Over Sham Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy...

Kodiak Sciences (KOD) to Release Quarterly Earnings on Thursday

Kodiak Sciences (NASDAQ:KOD) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 26. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-3-26-kodiak-sciences-inc-stock...

Boone Capital Management LLC Invests $11.72 Million in Kodiak Sciences Inc. $KOD

Boone Capital Management LLC bought a new position in shares of Kodiak Sciences Inc. (NASDAQ:KOD - Free Report) during the third quarter, according to its most recent Form 13F filing with the SEC...

Bruce & Co. Inc. Sells 43,692 Shares of Kodiak Sciences Inc. $KOD

Bruce & Co. Inc. decreased its position in shares of Kodiak Sciences Inc. (NASDAQ:KOD - Free Report) by 13.5% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned...

Investment Firm Doubles Down on Biotech Stock, Adds 386,000 Shares, According to Recent SEC Filing

Key PointsAcquired 386,000 shares of Kodiak Sciences (NASDAQ: KOD); estimated transaction value of $7.90 million based on quarterly average pricing...

TD Asset Management Inc Acquires New Stake in Kodiak Sciences Inc. $KOD

TD Asset Management Inc bought a new position in shares of Kodiak Sciences Inc. (NASDAQ:KOD - Free Report) during the 3rd quarter, according to the company in its most recent filing with the SEC. The...

Kodiak Sciences Inc. (NASDAQ:KOD) Receives Consensus Rating of "Moderate Buy" from Brokerages

Kodiak Sciences Inc. (NASDAQ:KOD - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the eight analysts that are currently covering the company, Marketbeat Ratings...

Kodiak Sciences Stock Up 480% as One Fund Discloses $53 Million Buy

Key PointsBaker Bros. Advisors increased its Kodiak Sciences stake by 2,608,696 shares; the estimated trade size was $53.42 million...

Kodiak Sciences (NASDAQ:KOD) Shares Down 5.9% - Here's What Happened

Kodiak Sciences (NASDAQ:KOD) Stock Price Down 5.9% - What's Next...

Kodiak Sciences shares surged following positive topline Phase 3 data for Zenkuda, demonstrating superiority in treating diabetic retinopathy.

Traders are highlighting significant short interest and high option open interest, speculating on a violent move higher due to a potential squeeze.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$1.03	--	--	N/A
Q3 '25	-$1.04	-$1.16	-11.85%	MISSED
Q2 '25	-$1.07	-$1.03	3.59%	BEAT
Q1 '25	-$0.89	-$1.09	-21.94%	MISSED
Q4 '24	-$0.88	-$0.84	4.91%	BEAT

KOD
Kodiak Sciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest KOD News

KODKodiak Sciences Inc